Request for Covid-19 Impact Assessment of this Report
The United States Cisatracurium Besylate Injection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cisatracurium Besylate Injection market, reaching US$ million by the year 2028. As for the Europe Cisatracurium Besylate Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Cisatracurium Besylate Injection players cover AbbVie, Fresenius Kabi, Meitheal Pharmaceuticals, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Cisatracurium Besylate Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
2 mg/mL
5 mg/mL
10 mg/mL
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinics
Recovery Center
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
AbbVie
Fresenius Kabi
Meitheal Pharmaceuticals
Pfizer
Sandoz
Teva
Shanghai Hengrui Pharmaceutical
Xianju Pharma
Jiangsu Singchn
Shanghai Sino Biopharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cisatracurium Besylate Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Cisatracurium Besylate Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Cisatracurium Besylate Injection by Country/Region, 2017, 2022 & 2028
2.2 Cisatracurium Besylate Injection Segment by Type
2.2.1 2 mg/mL
2.2.2 5 mg/mL
2.2.3 10 mg/mL
2.3 Cisatracurium Besylate Injection Sales by Type
2.3.1 Global Cisatracurium Besylate Injection Sales Market Share by Type (2017-2022)
2.3.2 Global Cisatracurium Besylate Injection Revenue and Market Share by Type (2017-2022)
2.3.3 Global Cisatracurium Besylate Injection Sale Price by Type (2017-2022)
2.4 Cisatracurium Besylate Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Recovery Center
2.5 Cisatracurium Besylate Injection Sales by Application
2.5.1 Global Cisatracurium Besylate Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Cisatracurium Besylate Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Cisatracurium Besylate Injection Sale Price by Application (2017-2022)
3 Global Cisatracurium Besylate Injection by Company
3.1 Global Cisatracurium Besylate Injection Breakdown Data by Company
3.1.1 Global Cisatracurium Besylate Injection Annual Sales by Company (2020-2022)
3.1.2 Global Cisatracurium Besylate Injection Sales Market Share by Company (2020-2022)
3.2 Global Cisatracurium Besylate Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Cisatracurium Besylate Injection Revenue by Company (2020-2022)
3.2.2 Global Cisatracurium Besylate Injection Revenue Market Share by Company (2020-2022)
3.3 Global Cisatracurium Besylate Injection Sale Price by Company
3.4 Key Manufacturers Cisatracurium Besylate Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cisatracurium Besylate Injection Product Location Distribution
3.4.2 Players Cisatracurium Besylate Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cisatracurium Besylate Injection by Geographic Region
4.1 World Historic Cisatracurium Besylate Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Cisatracurium Besylate Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Cisatracurium Besylate Injection Annual Revenue by Geographic Region
4.2 World Historic Cisatracurium Besylate Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Cisatracurium Besylate Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Cisatracurium Besylate Injection Annual Revenue by Country/Region
4.3 Americas Cisatracurium Besylate Injection Sales Growth
4.4 APAC Cisatracurium Besylate Injection Sales Growth
4.5 Europe Cisatracurium Besylate Injection Sales Growth
4.6 Middle East & Africa Cisatracurium Besylate Injection Sales Growth
5 Americas
5.1 Americas Cisatracurium Besylate Injection Sales by Country
5.1.1 Americas Cisatracurium Besylate Injection Sales by Country (2017-2022)
5.1.2 Americas Cisatracurium Besylate Injection Revenue by Country (2017-2022)
5.2 Americas Cisatracurium Besylate Injection Sales by Type
5.3 Americas Cisatracurium Besylate Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cisatracurium Besylate Injection Sales by Region
6.1.1 APAC Cisatracurium Besylate Injection Sales by Region (2017-2022)
6.1.2 APAC Cisatracurium Besylate Injection Revenue by Region (2017-2022)
6.2 APAC Cisatracurium Besylate Injection Sales by Type
6.3 APAC Cisatracurium Besylate Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cisatracurium Besylate Injection by Country
7.1.1 Europe Cisatracurium Besylate Injection Sales by Country (2017-2022)
7.1.2 Europe Cisatracurium Besylate Injection Revenue by Country (2017-2022)
7.2 Europe Cisatracurium Besylate Injection Sales by Type
7.3 Europe Cisatracurium Besylate Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cisatracurium Besylate Injection by Country
8.1.1 Middle East & Africa Cisatracurium Besylate Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Cisatracurium Besylate Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Cisatracurium Besylate Injection Sales by Type
8.3 Middle East & Africa Cisatracurium Besylate Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cisatracurium Besylate Injection
10.3 Manufacturing Process Analysis of Cisatracurium Besylate Injection
10.4 Industry Chain Structure of Cisatracurium Besylate Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cisatracurium Besylate Injection Distributors
11.3 Cisatracurium Besylate Injection Customer
12 World Forecast Review for Cisatracurium Besylate Injection by Geographic Region
12.1 Global Cisatracurium Besylate Injection Market Size Forecast by Region
12.1.1 Global Cisatracurium Besylate Injection Forecast by Region (2023-2028)
12.1.2 Global Cisatracurium Besylate Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cisatracurium Besylate Injection Forecast by Type
12.7 Global Cisatracurium Besylate Injection Forecast by Application
13 Key Players Analysis
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie Cisatracurium Besylate Injection Product Offered
13.1.3 AbbVie Cisatracurium Besylate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 Fresenius Kabi
13.2.1 Fresenius Kabi Company Information
13.2.2 Fresenius Kabi Cisatracurium Besylate Injection Product Offered
13.2.3 Fresenius Kabi Cisatracurium Besylate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Fresenius Kabi Main Business Overview
13.2.5 Fresenius Kabi Latest Developments
13.3 Meitheal Pharmaceuticals
13.3.1 Meitheal Pharmaceuticals Company Information
13.3.2 Meitheal Pharmaceuticals Cisatracurium Besylate Injection Product Offered
13.3.3 Meitheal Pharmaceuticals Cisatracurium Besylate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Meitheal Pharmaceuticals Main Business Overview
13.3.5 Meitheal Pharmaceuticals Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Cisatracurium Besylate Injection Product Offered
13.4.3 Pfizer Cisatracurium Besylate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Sandoz
13.5.1 Sandoz Company Information
13.5.2 Sandoz Cisatracurium Besylate Injection Product Offered
13.5.3 Sandoz Cisatracurium Besylate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Sandoz Main Business Overview
13.5.5 Sandoz Latest Developments
13.6 Teva
13.6.1 Teva Company Information
13.6.2 Teva Cisatracurium Besylate Injection Product Offered
13.6.3 Teva Cisatracurium Besylate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Teva Main Business Overview
13.6.5 Teva Latest Developments
13.7 Shanghai Hengrui Pharmaceutical
13.7.1 Shanghai Hengrui Pharmaceutical Company Information
13.7.2 Shanghai Hengrui Pharmaceutical Cisatracurium Besylate Injection Product Offered
13.7.3 Shanghai Hengrui Pharmaceutical Cisatracurium Besylate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Shanghai Hengrui Pharmaceutical Main Business Overview
13.7.5 Shanghai Hengrui Pharmaceutical Latest Developments
13.8 Xianju Pharma
13.8.1 Xianju Pharma Company Information
13.8.2 Xianju Pharma Cisatracurium Besylate Injection Product Offered
13.8.3 Xianju Pharma Cisatracurium Besylate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Xianju Pharma Main Business Overview
13.8.5 Xianju Pharma Latest Developments
13.9 Jiangsu Singchn
13.9.1 Jiangsu Singchn Company Information
13.9.2 Jiangsu Singchn Cisatracurium Besylate Injection Product Offered
13.9.3 Jiangsu Singchn Cisatracurium Besylate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Jiangsu Singchn Main Business Overview
13.9.5 Jiangsu Singchn Latest Developments
13.10 Shanghai Sino Biopharma
13.10.1 Shanghai Sino Biopharma Company Information
13.10.2 Shanghai Sino Biopharma Cisatracurium Besylate Injection Product Offered
13.10.3 Shanghai Sino Biopharma Cisatracurium Besylate Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Shanghai Sino Biopharma Main Business Overview
13.10.5 Shanghai Sino Biopharma Latest Developments
14 Research Findings and Conclusion
Table 1. Cisatracurium Besylate Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Cisatracurium Besylate Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 2 mg/mL
Table 4. Major Players of 5 mg/mL
Table 5. Major Players of 10 mg/mL
Table 6. Global Cisatracurium Besylate Injection Sales by Type (2017-2022) & (K Units)
Table 7. Global Cisatracurium Besylate Injection Sales Market Share by Type (2017-2022)
Table 8. Global Cisatracurium Besylate Injection Revenue by Type (2017-2022) & ($ million)
Table 9. Global Cisatracurium Besylate Injection Revenue Market Share by Type (2017-2022)
Table 10. Global Cisatracurium Besylate Injection Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Cisatracurium Besylate Injection Sales by Application (2017-2022) & (K Units)
Table 12. Global Cisatracurium Besylate Injection Sales Market Share by Application (2017-2022)
Table 13. Global Cisatracurium Besylate Injection Revenue by Application (2017-2022)
Table 14. Global Cisatracurium Besylate Injection Revenue Market Share by Application (2017-2022)
Table 15. Global Cisatracurium Besylate Injection Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Cisatracurium Besylate Injection Sales by Company (2020-2022) & (K Units)
Table 17. Global Cisatracurium Besylate Injection Sales Market Share by Company (2020-2022)
Table 18. Global Cisatracurium Besylate Injection Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Cisatracurium Besylate Injection Revenue Market Share by Company (2020-2022)
Table 20. Global Cisatracurium Besylate Injection Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Cisatracurium Besylate Injection Producing Area Distribution and Sales Area
Table 22. Players Cisatracurium Besylate Injection Products Offered
Table 23. Cisatracurium Besylate Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Cisatracurium Besylate Injection Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Cisatracurium Besylate Injection Sales Market Share Geographic Region (2017-2022)
Table 28. Global Cisatracurium Besylate Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Cisatracurium Besylate Injection Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Cisatracurium Besylate Injection Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Cisatracurium Besylate Injection Sales Market Share by Country/Region (2017-2022)
Table 32. Global Cisatracurium Besylate Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Cisatracurium Besylate Injection Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Cisatracurium Besylate Injection Sales by Country (2017-2022) & (K Units)
Table 35. Americas Cisatracurium Besylate Injection Sales Market Share by Country (2017-2022)
Table 36. Americas Cisatracurium Besylate Injection Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Cisatracurium Besylate Injection Revenue Market Share by Country (2017-2022)
Table 38. Americas Cisatracurium Besylate Injection Sales by Type (2017-2022) & (K Units)
Table 39. Americas Cisatracurium Besylate Injection Sales Market Share by Type (2017-2022)
Table 40. Americas Cisatracurium Besylate Injection Sales by Application (2017-2022) & (K Units)
Table 41. Americas Cisatracurium Besylate Injection Sales Market Share by Application (2017-2022)
Table 42. APAC Cisatracurium Besylate Injection Sales by Region (2017-2022) & (K Units)
Table 43. APAC Cisatracurium Besylate Injection Sales Market Share by Region (2017-2022)
Table 44. APAC Cisatracurium Besylate Injection Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Cisatracurium Besylate Injection Revenue Market Share by Region (2017-2022)
Table 46. APAC Cisatracurium Besylate Injection Sales by Type (2017-2022) & (K Units)
Table 47. APAC Cisatracurium Besylate Injection Sales Market Share by Type (2017-2022)
Table 48. APAC Cisatracurium Besylate Injection Sales by Application (2017-2022) & (K Units)
Table 49. APAC Cisatracurium Besylate Injection Sales Market Share by Application (2017-2022)
Table 50. Europe Cisatracurium Besylate Injection Sales by Country (2017-2022) & (K Units)
Table 51. Europe Cisatracurium Besylate Injection Sales Market Share by Country (2017-2022)
Table 52. Europe Cisatracurium Besylate Injection Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Cisatracurium Besylate Injection Revenue Market Share by Country (2017-2022)
Table 54. Europe Cisatracurium Besylate Injection Sales by Type (2017-2022) & (K Units)
Table 55. Europe Cisatracurium Besylate Injection Sales Market Share by Type (2017-2022)
Table 56. Europe Cisatracurium Besylate Injection Sales by Application (2017-2022) & (K Units)
Table 57. Europe Cisatracurium Besylate Injection Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Cisatracurium Besylate Injection Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Cisatracurium Besylate Injection Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Cisatracurium Besylate Injection Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Cisatracurium Besylate Injection Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Cisatracurium Besylate Injection Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Cisatracurium Besylate Injection Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Cisatracurium Besylate Injection Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Cisatracurium Besylate Injection Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Cisatracurium Besylate Injection
Table 67. Key Market Challenges & Risks of Cisatracurium Besylate Injection
Table 68. Key Industry Trends of Cisatracurium Besylate Injection
Table 69. Cisatracurium Besylate Injection Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Cisatracurium Besylate Injection Distributors List
Table 72. Cisatracurium Besylate Injection Customer List
Table 73. Global Cisatracurium Besylate Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Cisatracurium Besylate Injection Sales Market Forecast by Region
Table 75. Global Cisatracurium Besylate Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Cisatracurium Besylate Injection Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Cisatracurium Besylate Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Cisatracurium Besylate Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Cisatracurium Besylate Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Cisatracurium Besylate Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Cisatracurium Besylate Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Cisatracurium Besylate Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Cisatracurium Besylate Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Cisatracurium Besylate Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Cisatracurium Besylate Injection Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Cisatracurium Besylate Injection Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Cisatracurium Besylate Injection Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Cisatracurium Besylate Injection Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Cisatracurium Besylate Injection Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Cisatracurium Besylate Injection Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Cisatracurium Besylate Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Cisatracurium Besylate Injection Revenue Market Share Forecast by Application (2023-2028)
Table 93. AbbVie Basic Information, Cisatracurium Besylate Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. AbbVie Cisatracurium Besylate Injection Product Offered
Table 95. AbbVie Cisatracurium Besylate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. AbbVie Main Business
Table 97. AbbVie Latest Developments
Table 98. Fresenius Kabi Basic Information, Cisatracurium Besylate Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Fresenius Kabi Cisatracurium Besylate Injection Product Offered
Table 100. Fresenius Kabi Cisatracurium Besylate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Fresenius Kabi Main Business
Table 102. Fresenius Kabi Latest Developments
Table 103. Meitheal Pharmaceuticals Basic Information, Cisatracurium Besylate Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Meitheal Pharmaceuticals Cisatracurium Besylate Injection Product Offered
Table 105. Meitheal Pharmaceuticals Cisatracurium Besylate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Meitheal Pharmaceuticals Main Business
Table 107. Meitheal Pharmaceuticals Latest Developments
Table 108. Pfizer Basic Information, Cisatracurium Besylate Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Pfizer Cisatracurium Besylate Injection Product Offered
Table 110. Pfizer Cisatracurium Besylate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Pfizer Main Business
Table 112. Pfizer Latest Developments
Table 113. Sandoz Basic Information, Cisatracurium Besylate Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Sandoz Cisatracurium Besylate Injection Product Offered
Table 115. Sandoz Cisatracurium Besylate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Sandoz Main Business
Table 117. Sandoz Latest Developments
Table 118. Teva Basic Information, Cisatracurium Besylate Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. Teva Cisatracurium Besylate Injection Product Offered
Table 120. Teva Cisatracurium Besylate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Teva Main Business
Table 122. Teva Latest Developments
Table 123. Shanghai Hengrui Pharmaceutical Basic Information, Cisatracurium Besylate Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. Shanghai Hengrui Pharmaceutical Cisatracurium Besylate Injection Product Offered
Table 125. Shanghai Hengrui Pharmaceutical Cisatracurium Besylate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Shanghai Hengrui Pharmaceutical Main Business
Table 127. Shanghai Hengrui Pharmaceutical Latest Developments
Table 128. Xianju Pharma Basic Information, Cisatracurium Besylate Injection Manufacturing Base, Sales Area and Its Competitors
Table 129. Xianju Pharma Cisatracurium Besylate Injection Product Offered
Table 130. Xianju Pharma Cisatracurium Besylate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Xianju Pharma Main Business
Table 132. Xianju Pharma Latest Developments
Table 133. Jiangsu Singchn Basic Information, Cisatracurium Besylate Injection Manufacturing Base, Sales Area and Its Competitors
Table 134. Jiangsu Singchn Cisatracurium Besylate Injection Product Offered
Table 135. Jiangsu Singchn Cisatracurium Besylate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Jiangsu Singchn Main Business
Table 137. Jiangsu Singchn Latest Developments
Table 138. Shanghai Sino Biopharma Basic Information, Cisatracurium Besylate Injection Manufacturing Base, Sales Area and Its Competitors
Table 139. Shanghai Sino Biopharma Cisatracurium Besylate Injection Product Offered
Table 140. Shanghai Sino Biopharma Cisatracurium Besylate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Shanghai Sino Biopharma Main Business
Table 142. Shanghai Sino Biopharma Latest Developments
List of Figures
Figure 1. Picture of Cisatracurium Besylate Injection
Figure 2. Cisatracurium Besylate Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cisatracurium Besylate Injection Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Cisatracurium Besylate Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Cisatracurium Besylate Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 2 mg/mL
Figure 10. Product Picture of 5 mg/mL
Figure 11. Product Picture of 10 mg/mL
Figure 12. Global Cisatracurium Besylate Injection Sales Market Share by Type in 2021
Figure 13. Global Cisatracurium Besylate Injection Revenue Market Share by Type (2017-2022)
Figure 14. Cisatracurium Besylate Injection Consumed in Hospital
Figure 15. Global Cisatracurium Besylate Injection Market: Hospital (2017-2022) & (K Units)
Figure 16. Cisatracurium Besylate Injection Consumed in Clinics
Figure 17. Global Cisatracurium Besylate Injection Market: Clinics (2017-2022) & (K Units)
Figure 18. Cisatracurium Besylate Injection Consumed in Recovery Center
Figure 19. Global Cisatracurium Besylate Injection Market: Recovery Center (2017-2022) & (K Units)
Figure 20. Global Cisatracurium Besylate Injection Sales Market Share by Application (2017-2022)
Figure 21. Global Cisatracurium Besylate Injection Revenue Market Share by Application in 2021
Figure 22. Cisatracurium Besylate Injection Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Cisatracurium Besylate Injection Revenue Market Share by Company in 2021
Figure 24. Global Cisatracurium Besylate Injection Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Cisatracurium Besylate Injection Revenue Market Share by Geographic Region in 2021
Figure 26. Global Cisatracurium Besylate Injection Sales Market Share by Region (2017-2022)
Figure 27. Global Cisatracurium Besylate Injection Revenue Market Share by Country/Region in 2021
Figure 28. Americas Cisatracurium Besylate Injection Sales 2017-2022 (K Units)
Figure 29. Americas Cisatracurium Besylate Injection Revenue 2017-2022 ($ Millions)
Figure 30. APAC Cisatracurium Besylate Injection Sales 2017-2022 (K Units)
Figure 31. APAC Cisatracurium Besylate Injection Revenue 2017-2022 ($ Millions)
Figure 32. Europe Cisatracurium Besylate Injection Sales 2017-2022 (K Units)
Figure 33. Europe Cisatracurium Besylate Injection Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Cisatracurium Besylate Injection Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Cisatracurium Besylate Injection Revenue 2017-2022 ($ Millions)
Figure 36. Americas Cisatracurium Besylate Injection Sales Market Share by Country in 2021
Figure 37. Americas Cisatracurium Besylate Injection Revenue Market Share by Country in 2021
Figure 38. United States Cisatracurium Besylate Injection Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Cisatracurium Besylate Injection Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Cisatracurium Besylate Injection Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Cisatracurium Besylate Injection Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Cisatracurium Besylate Injection Sales Market Share by Region in 2021
Figure 43. APAC Cisatracurium Besylate Injection Revenue Market Share by Regions in 2021
Figure 44. China Cisatracurium Besylate Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Cisatracurium Besylate Injection Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Cisatracurium Besylate Injection Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Cisatracurium Besylate Injection Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Cisatracurium Besylate Injection Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Cisatracurium Besylate Injection Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Cisatracurium Besylate Injection Sales Market Share by Country in 2021
Figure 51. Europe Cisatracurium Besylate Injection Revenue Market Share by Country in 2021
Figure 52. Germany Cisatracurium Besylate Injection Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Cisatracurium Besylate Injection Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Cisatracurium Besylate Injection Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Cisatracurium Besylate Injection Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Cisatracurium Besylate Injection Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Cisatracurium Besylate Injection Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Cisatracurium Besylate Injection Revenue Market Share by Country in 2021
Figure 59. Egypt Cisatracurium Besylate Injection Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Cisatracurium Besylate Injection Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Cisatracurium Besylate Injection Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Cisatracurium Besylate Injection Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Cisatracurium Besylate Injection Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Cisatracurium Besylate Injection in 2021
Figure 65. Manufacturing Process Analysis of Cisatracurium Besylate Injection
Figure 66. Industry Chain Structure of Cisatracurium Besylate Injection
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...